• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, July 25, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

How well do vaccines work? Research reveals measles vaccine efficacy

Bioengineer by Bioengineer
March 7, 2019
in Health
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Virginia Tech

The recent measles outbreaks across the country emphasize the importance of vaccinations.

WATCH VIDEO: https://video.vt.edu/media/0_vltvihxh

“For many infectious diseases, we rely on herd immunity to prevent outbreaks of vaccine-preventable infections. Herd immunity is the protection of the ‘herd,’ our population, by preventing infections in the vast majority people,” said Kate Langwig, an infectious disease ecologist at Virginia Tech. “We can calculate the percentage of the population that needs to be vaccinated to prevent diseases from spreading and maintain herd immunity. For some pathogens, like measles, the number that needs to vaccinated is very high because the measles virus spreads so easily.”

Langwig, an assistant professor in the Department of Biological Sciences in the College of Science at Virginia Tech, is researching ways in which vaccine efficacy can be improved.

The measles vaccine has been shown to have 97 percent efficacy, but “understanding the circumstances that contribute to vaccine ineffectiveness can help to better protect populations,” Langwig said.

Langwig and her lab ran mathematical modeling simulations to determine if vaccine efficacy might be lower when individuals are exposed to high pathogen doses, and when individuals vary in their susceptibility.

For example, if you have been vaccinated against the measles, but someone sneezes very close to your face, or you’re caring for a sick kid who is sneezing, coughing, etc., are you more likely to get sick? In addition, if you’re run down (maybe from chasing that kid the week earlier), are you more likely to get infected even if you’ve been vaccinated?

Langwig and her lab found in their simulations that vaccines are predicted to be less effective at higher pathogen doses and when individuals in the population have similar susceptibility. These findings were recently published in Scientific Reports.

“Susceptibility, meaning how likely an individual is to get infected, is also important. Individuals that are younger or have poor nutrition can be more likely to get infected, even if they have been vaccinated. We found that populations that have more variable susceptibility have higher vaccine efficacy,” said Langwig, an affiliated faculty member of the Global Change Center, an arm of the Fralin Life Science Institute.

Langwig and her lab were interested in validating their simulations with some real-world data, so they did a systematic literature review with help from Virginia Tech undergraduate researchers to determine whether there were examples of diseases where vaccines efficacy is reduced at high doses.

“What we found was a bit of a shock – there are a very small number of studies that test whether vaccines are effective across multiple pathogen doses. We reviewed almost 6,000 articles and identified only about a dozen studies that had tested vaccines across multiple pathogen doses. Within those few studies, the pattern was generally consistent with our simulation – vaccine efficacy tended to be lower at high pathogen doses,” said Langwig.

They did find that some vaccines did offer complete protection regardless of pathogen dose in several model organisms, suggesting that not all vaccines are less effective when individuals are exposed to high doses.

Extrapolation to human systems should be done with care, but this research helps increase the understanding of host susceptibility, pathogen dose, and vaccine efficacy.

“One thing that surprised us is that many scientists are vaguely aware that vaccines might fail at high pathogen doses, but there were a very small number of studies that had ever examined this,” said Langwig.

Langwig is currently collaborating with another lab to test vaccine efficacy and different pathogen doses in a species of rainbow trout. They will continue to design mathematical models to test predictions in real-world situations to determine how populations can be further protected.

###

Media Contact
Kristin Rose
[email protected]

Original Source

https://vtnews.vt.edu/articles/2019/03/022819-Fralin-Kate-Langwig-vaccine-efficacy.html

Related Journal Article

http://dx.doi.org/10.1038/s41598-019-39698-x

Tags: Immunology/Allergies/AsthmaMathematics/StatisticsMedicine/HealthVaccines
Share12Tweet8Share2ShareShareShare2

Related Posts

Single-Cell Atlas Links Chemokines to Type 2 Diabetes

July 20, 2025
blank

AI Diagnoses Structural Heart Disease via ECG

July 17, 2025

Functional Regimes Shape Soil Microbiome Response

July 17, 2025

Stealth Adaptations in Large Ichthyosaur Flippers

July 17, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15
  • AI Achieves Breakthrough in Drug Discovery by Tackling the True Complexity of Aging

    70 shares
    Share 28 Tweet 18
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    43 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Additive Manufacturing of Monolithic Gyroidal Solid Oxide Cells

Machine Learning Uncovers Sorghum’s Complex Mold Resistance

Pathology Multiplexing Revolutionizes Disease Mapping

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.